Roman Butler Fullerton & Co. Sells 563 Shares of National Health Investors, Inc. (NYSE:NHI)

Roman Butler Fullerton & Co. lessened its stake in National Health Investors, Inc. (NYSE:NHI) by 6.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,654 shares of the real estate investment trust’s stock after selling 563 shares during the period. Roman Butler Fullerton & Co.’s holdings in National Health Investors were worth $472,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of NHI. Raymond James & Associates grew its holdings in National Health Investors by 7.0% during the 1st quarter. Raymond James & Associates now owns 21,335 shares of the real estate investment trust’s stock worth $1,259,000 after acquiring an additional 1,403 shares during the period. Raymond James Financial Services Advisors Inc. grew its holdings in National Health Investors by 5.7% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 6,806 shares of the real estate investment trust’s stock worth $402,000 after acquiring an additional 368 shares during the period. PNC Financial Services Group Inc. grew its holdings in National Health Investors by 29.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the real estate investment trust’s stock worth $300,000 after acquiring an additional 1,150 shares during the period. MetLife Investment Management LLC grew its holdings in National Health Investors by 53.0% during the 1st quarter. MetLife Investment Management LLC now owns 22,969 shares of the real estate investment trust’s stock worth $1,355,000 after acquiring an additional 7,957 shares during the period. Finally, Panagora Asset Management Inc. acquired a new position in shares of National Health Investors in the 1st quarter valued at $1,752,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

Insider Transactions at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford acquired 10,000 shares of National Health Investors stock in a transaction dated Tuesday, February 27th. The stock was bought at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the purchase, the director now directly owns 110,185 shares in the company, valued at approximately $6,466,757.65. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 7.26% of the company’s stock.

National Health Investors Price Performance

NHI stock opened at $60.41 on Friday. The stock has a 50-day moving average price of $58.64 and a two-hundred day moving average price of $55.23. The stock has a market cap of $2.62 billion, a PE ratio of 19.30 and a beta of 0.95. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90. National Health Investors, Inc. has a 1 year low of $47.54 and a 1 year high of $62.93.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.96%. National Health Investors’s dividend payout ratio is 115.02%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on NHI shares. Wedbush boosted their price target on shares of National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a report on Monday, March 18th. Deutsche Bank Aktiengesellschaft started coverage on shares of National Health Investors in a report on Tuesday, January 30th. They issued a “buy” rating and a $69.00 price target for the company. Wells Fargo & Company raised shares of National Health Investors from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $55.00 to $63.00 in a report on Monday, February 26th. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Truist Financial boosted their price objective on shares of National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research report on Thursday, April 4th. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, National Health Investors has a consensus rating of “Hold” and a consensus target price of $60.50.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.